INTRODUCTION
A large body of evidence has indicated that trans fatty acids TFA , the geometrical isomers of unsaturated fatty acids possessing at least one double bond in the trans configuration, have multiple adverse effects on cardiovascular disease CVD , including dyslipidemia, endothelial dysfunction, and inflammation 1, 2 . TFA occur naturally in some meat and dairy products from ruminant animals and are found industrially in processed, partially hydrogenated vegetable oil. Catalytic hydrogenation has been used in food manufacturing to turn liquid oils into a solid form of fat and to add stability against autoxidation. Consumption of industrial TFA, mainly composed of elaidic acid trans-low-density lipoprotein LDL or total cholesterol concentration to high-density lipoprotein HDL cholesterol in blood and to increase the risk for CVD 3, 4 .
Fats from ruminants, such as cows, sheep, and goats, contain 2-9 TFA, and ruminant TFA are produced by bacterial metabolism of polyunsaturated fatty acids in the rumen. While industrial TFA have been linked to CVD, the relationship between naturally occurring ruminant TFA, which predominantly contain vaccenic acid trans-11-octadecenoic acid, 11t-18:1 , and heart disease is not clear. While evidence from human studies has shown no association between consumption of ruminant TFA and CVD risk 5, 6 , a non-significant inverse and a non-significant positive association between the consumption of ruminant TFA and risk of CVD have been reported 6 9 . These indistinct results have concerned many people, leading officials to take measures against TFA consumption in many countries. Some countries and local agencies have implemented a ban on TFA in foodstuffs, with some calling for the elimination of TFA, whereas other countries that have a large-scale dairy farming industry, such as Denmark, have banned the use of industrial TFA in foods, but the ban excludes TFA from ruminant animal products. Total TFA in foods are mainly composed of trans-octadecenoic acid 18:1 approximately 80-90 10 . Industrial and ruminant TFA reportedly consist of exactly the same individual trans-18:1 isomers 11 , although the relative proportion is significantly different between these sources. In industrial TFA, 9t-and 10t-18:1 are predominant with smaller proportions of 6-, 8-, 11-, and 12t-18:1 11 13 , whereas the major isomer of ruminant TFA is 11t-18:1, with lower proportions of 13-/14-, 9-, 10-, and 12t-18:1 11, 14 .
However, most previous studies have evaluated the increased risk of CVD caused by total TFA from industrial and/or ruminant fats, but did not account for the presence of specific isomers. The differential effects of industrial and ruminant TFA on CVD risk could be due to the presence and properties of specific harmful or beneficial isomers since individual TFA isomers could potentially have different roles in the etiology of heart disease. In addition, 11t-18:1 can be metabolized to conjugated linoleic acid CLA by Δ9-desaturase in animals and humans 15 , which has been reported to have beneficial effects on CVD in animal studies 16, 17 , although it is still not clear whether CLA exhibits beneficial effects in humans 18 20 . Therefore, studies comparing the effects of individual TFA isomers are needed, rather than solely comparing the sources of TFA. Moreover, in vivo studies are needed to clarify the biological availability and fate of individual TFA isomers so that appropriate TFA policies can be determined.
In the present study, we investigated the differential distribution of the three most abundant industrial and natural TFA positional isomers 9t-, 10t-and 11t-18:1 into tissues and erythrocytes of imprinting control region ICR mice.
To compare the propensity of each isomer s accumulation in tissues, we also fed mice with a diet containing equal proportions of these TFA isomers. In addition, to clarify the differential effects of double-bond position on fatty acid metabolism, we determined the catabolic rate of these TFA isomers through beta-oxidation and catabolism to CO 2 using isotope-ratio mass spectrometry IRMS 21, 22 
Animal care and diet
Animals were handled in accordance with the guidelines established by the Institutional Animal Care and Use Committee of the Tokyo University of Marine Science and Technology. Eight-week-old male ICR mice were purchased from Japan SLC Shizuoka, Japan . The ICR mouse is a phenotypically normal and multipurpose research animal model that is used in such fields as toxicology, pharmacology, and immunology. We considered that the ICR strain is a suitable model for the purpose of this lipid metabolism study. Six mice were housed per cage under standard conditions with a 12:12-h light-dark cycle at 22 1 and 50 humidity. The animals had free access to food and tap water. Mice were fed rodent chow MF Oriental Yeast, Tokyo, Japan and switched to experimental diets after acclimation for one week. To elucidate the distribution of TFA isomers into tissues, individual TFA ethyl esters were mixed into powdered rodent chow MF and fed to mice at concentrations of 1 TFA ethyl ester by energy content kcal for 2 or 4 weeks. In addition, a TFA ethyl ester mixture 9t-18:1*, 10t-18:1*, and 11t-18:1*; 1 kcal each was fed at a concentration of 3 kcal for 3 weeks to compare the propensity for accumulation in tissues between the three isomers. Mice fed a diet supplemented with 9-cis-octadecenoic acid oleic acid: OLA, 9c-18:1 ethyl ester at concentrations of 1 or 3 kcal were used as a control group. The fatty acid composition of the experimental diets was analyzed by gas chromatography GC Table 1 . At the end of experiment, blood samples were collected in tubes with K3-EDTA from the cervical vein of animals under diethyl ether anesthesia. After euthanasia by cervical dislocation, the liver, epididymal white adipose tissue WAT , and heart were collected and stored at 60 until lipid analysis.
Blood sample preparation
Red blood cells were isolated by adding 1.5 mL of whole blood to 5 mL of saline, and then cells were centrifuged at 1,000 g for 10 min at 4 . The supernatant with plasma and platelets was then removed. This procedure was repeated two times. The erythrocytes were burst with pure water and membranes were separated by centrifugation at 15,000 g for 20 min at 4 .
Fatty acid analysis
Total lipids were extracted according to the method of Folch et al. 23 . Fatty acids were then transmethylated in the presence of boron trifluoride in methanol as established by the American Oil Chemists Society AOCS official method, Ce 1b-89 24 . Fatty acid methyl esters were extracted with n-hexane, and then the hexane phase was collected and the solvent evaporated under nitrogen gas. The fatty acid composition was analyzed with a GC-flame ionization detector GC-FID system TRACE GC Ultra, Thermo Fisher Scientific, Waltham, MA equipped with a capillary column SLB-IL111, 100 m 0.25 mm ID, SigmaAldrich Japan K.K., Tokyo, Japan . The temperature of the injection port and detector was 250 . The initial column temperature was 160 for 35 min, followed by an increase of 15 /min up to 240 and holding for 10 min. Helium was used as the carrier gas at a flow rate of 1.2 mL/min. Individual fatty acids were identified by comparison with the retention times of standards Supelco 37 Component FAME Mix, Sigma-Aldrich Japan K.K. . Heptadecanoic acid was added prior to lipid extraction from tissues as an internal standard for the quantification of fatty acids 25 . Analyzed results reflect total amount of fatty acid including both free and esterified fatty acids. Labeled fatty acids were quantified using GC-chemical ionization mass spectrometry GC-CI/MS; GC: TRACE GC Ultra, CI/MS: ITQ1100, Thermo Fisher Scientific . The methyl-esterified sample lipid was injected into the GC-CI/ MS using the splitless mode. The injection port and detector temperature was 250 . The initial column temperature was held at 180 for 30 min and subsequently increased at a rate of 10 /min to a maximum of 240 and then held for 15 min. The carrier gas was helium, provided at a flow rate of 1.0 mL/min. GC separation was achieved using an SP-2560 capillary column with 0.25-μm film thickness 100 m 0.25 mm ID, Sigma-Aldrich Japan K.K. . The mass spectrum was obtained with 70 eV chemical ionization methane as regent gas and detected with scan mode m/z 50-650 . The target compounds were detected at m/z 297 M 1 , unlabeled 9t-, 10t-, and 11t-18:1 , 300 M 4 , labeled trans 9-, 10-, and 11-18:1 , 295 M 1 , unlabeled CLA , and 298 M 4 , labeled CLA .
Analysis of the catabolic rates of respective TFA
Respective TFA emulsions were prepared as described in our previous work 26 . In brief, individually labeled TFA ethyl esters were mixed with triolein, Triton X-100, and distilled water. The mixture was then emulsified using a Sonifier 250 ultrasonic homogenizer Branson Japan, Kanagawa, Japan . Fifteen ICR mice were divided equally into 3 groups after acclimation for one week. Individual TFA emulsions of 10 mL/kg TFA dose 400 mg/kg were administered orally to the animals. Each mouse was then placed in a 450-mL plastic vessel for 5 min, and a sample of expired gas was collected in a 50-mL syringe. gas was analyzed using IRMS ANCA-GSL, SerCon, Cheshire, UK . First, the natural abundance of 13 C and 12 C in G1-grade CO 2 manufactured by Taiyo Nippon Sanso Tokyo, Japan was analyzed by SI Science Sugito, Japan, δ 13 C-Vienna Pee Dee Belemnite VPDB 29.6 . The CO 2 was diluted 10 times with nitrogen gas, and the mixed gas was packed into a 12-mL evacuated vial. The mixed gas was used as a standard to adjust the measured value using IRMS. Next, the actual ratio of 13 CO 2 and 12 CO 2 in the expired CO 2 gas from the mice was analyzed. The following parameters were used: injection time, 12 s; column temperature, 100 ; carrier gas, helium; carrier gas flow rate, 60 mL/min; ionization method, electron ionization. The δ 13 C values in each sample of expired gas were calculated using Equation 1 27 : Ct represents the δ
13
C value at time t after sample administration, and δ 13 C 0 represents the δ 13 C value before sample administration.
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Statistical analysis
Statistical analysis was performed using an ANOVA with Tukey-Kramer test. The difference was considered significant when p was less than 0.05.
RESULTS
Distribution of individual TFA isomers in tissues
9t-18:1* is generally considered the primary cause of CVD among all TFA isomers, because it is typically found in the highest proportion in industrial TFA. Therefore, we initially investigated the distribution of 9t-18:1* in wholebody tissues in order to identify the specific tissues in which 9t-18:1* predominantly accumulates. Consumption of 9t-18:1* at 1 kcal was distributed in different proportions to all tissues except for the brain Fig. 1 . The highest proportion of 9t-18:1* among whole-body tissues was observed in the heart. Based on our results, we selected the liver, WAT and heart, which are the major organs for lipid metabolism, as target organs for this study. In addition, we also investigated the erythrocyte membrane because trans-18:1 is known to accumulate primarily in the phospholipid fraction of plasma as well as the TAG fraction of organs 15 .
Next, we fed mice with individual isomers for 2 or 4 weeks to identify the differences in accumulation in tissues. The content of stable isotope-labeled TFA and 9c,11t-CLA* thought to be formed from 11t-18:1* in the total lipid from each tissue is shown in Table 2 . Although there was no detectable TFA in the control group, enrichment of each isomer in respective tissues was observed for all TFA-treated groups. When compared to the amounts of respective isomers, 10t-18:1 was present at relatively low levels in the liver and WAT. The accumulated amount in the heart was significantly different, with the relative content of isomers found to be 9t-11t-10t-18:1. The relative content of respective isomers in the erythrocytes was 9t-, 11t-10t-18:1 at 2 weeks. Such a trend was observed at 4 weeks, but not significant. GC-CI/MS analysis revealed that endogenously synthesized CLA from ingested TFA was observed only in the 11t-18:1* group. The relative content of 9c,11t-CLA* in respective tissues was WAT liver heart at 4 weeks, but was not detected in erythrocytes. No other CLA thought to be formed from 9t-or 10t-18:1* was detected in this study. Fig. 1 Distribution of 9t-18:1* in mice tissues. ICR mice were fed 9t-18:1* at a concentration of 1 kcal% for 1 week. Each value represents the mean ± standard error. Different letters indicate significant differences at p < 0.05.
Comparison of TFA isomer accumulation in mice fed
TFA mixture Several kinds of trans-18:1 isomers are present in food, including meats, dairy products, and industrially processed, partially hydrogenated vegetable oil. To clarify whether trans-18:1 isomers influence each other s uptake into organs, we fed mice a TFA mixture containing equal amounts of 9t, 10t, and 11t-18:1* for 3 weeks. Separation of 9t, 10t, and 11t-18:1* was achieved using a GC-FID equipped with a SLB-IL111 column, as previously described 28 . Figure 2 shows the labeled-TFA content in lipids from each tissue. A significant difference was observed in the heart, but not in the WAT, liver, or erythrocytes. The relative content of the respective labeled TFA isomers was 9t-11t-10t-18:1*, and this trend was identical to those of mice fed TFA isomers individually. The 9t-18:1* content in the heart was 4.5-and 2.0-fold higher than 10t-and 11t-18:1*, respectively.
Differential catabolic rates for TFA isomers
Dietary fatty acids are catabolized through beta-oxidation in the mitochondria to acetyl-CoA, which enters the citric acid cycle to be oxidized to CO 2 . Whole-body oxidation of fatty acids has been measured by the administration of 13 C -labeled fatty acids followed by measurement of expired 13 CO 2 29, 30 . To elucidate whether the metabolic rate of each TFA isomer depended upon double-bond position, we fed mice with individual isomers and calculated Δ 13 C values from the carbon isotope ratios in expired CO 2 gas samples using an IRMS system 26, 27 . Δ 13 C values rapidly increased in the first 90 min of labeled-TFA ingestion and peaked during 75-105 min in all test groups Fig. 3 . The metabolic rate was significantly higher in the 10t-18:1* group than that of 9t-and 11t-18:1* during 75-120 min and 105-120 min, respectively. The greater Δ 13 C values rapidly decreased to the same level of other isomers by 240 min. There was no difference in the metabolic rate between 9t-and 11t-18:1* during the experiment, and their Δ
13
C values gradually decreased from 120 min until the end of the experiment. These results indicate that 10t-18:1* was the preferred substrate for beta-oxidation and was most effectively catabolized into 13 CO 2 via the citric acid cycle among the three isomers. Table 2 TFA content in total lipid from tissues (g/100 g lipid). 
DISCUSSION
Previous reports have demonstrated the incorporation and accumulation of dietary TFA into blood, organs, and tissues 31 33 . Our results are generally consistent with reports showing that dietary 9t-18:1 is incorporated into various tissues, and its proportion to total lipid was different depending on the tissue Fig. 1 . Further, we found that each isomer differentially accumulates in different tissues. Although no difference was observed in the liver and WAT, the proportion of 9t-18:1* to total lipid in the heart was the highest, followed by that of 11t-18:1* and 10t-18:1* Table 2 . Such a difference was also observed in the mice fed the labeled-TFA mixture Fig. 2 . It appears that TFA isomers did not interfere with each other s incorporation. In this study, we did not examine the dose or time effect of TFA accumulation. However, we found that feeding the TFA mixture for 3 weeks led to accumulation of each isomer at the same levels as 4 weeks of feeding with the individual isomers, suggesting that steady-state pharmacokinetics are achieved by 3 weeks of feeding under these experimental conditions. Our results clearly show that the difference in accumulation of individual isomers can be attributed to their physical and structural properties.
It is well known that trans-18:1 accumulates primarily in the phospholipid and TAG fractions of plasma and tissues. In the present study, a difference in the accumulation was observed in the heart and erythrocytes, which have a large proportion of phospholipids among total lipids. It has been reported that trans-18:1 positional isomers are positively incorporated into the 1-acyl position of PtdCho and are strictly excluded from the 2-acyl position relative to OLA 34 .
Moreover, according to that report, the incorporation of 10t-18:1 into human plasma 1-acyl PtdCho is approximately 50 lower than 9t-and 11t-18:1, and 10t-18:1 and 11t-18:1 are strictly excluded from the 2-acyl position of PtdCho compared to 9t-18:1. In vitro studies have demonstrated that PtdCho acyltransferases distinguish differences in the structures of isomers 18:1 and C18:2 35 . Therefore, we considered that PtdCho acyltransferases are sensitive to the number and position of double bonds, and this specificity results in differences in accumulation of respective isomers in the phospholipids. However, further analysis of the respective lipid fractions is required to clarify the differences in the specificity of acyltransferases, including PtdCho, TAG, and cholesteryl ester transferases, among trans-18:1 isomers in different tissues. Consistent with a previous study 36 , we observed a timedependent formation of 9c,11t-CLA from ingested 11t-18:1* 40 . Such a difference between even-and odd-numbered trans 18:1 isomers may be inferred from the beta-oxidation process 39, 41 , in which odd-numbered 18:1 isomers need an additional modification to move the double bond from the 3-position to the 2-position by Δ3-cis-Δ2-trans-enoyl-CoA isomerase for beta-oxidation to proceed, compared with the even-numbered 18:1 isomers and the intermediates produced by fatty acyl-CoA dehydrogenase. These previous reports support our in vivo study demonstrating that the lower accumulation of 10t-18:1* in mouse tissues, compared with the other isomers, was partly due to its propensity to be catabolized through beta-oxidation. It has been reported that lipases in the gastrointestinal tract can discriminate against the fatty acid ethyl esters 42 ,
suggesting that differential hydrolytic rates between TFA isomers might affect some metabolic phenomena including accumulation and catabolic rate. Unfortunately, we did not examine digestive absorption and blood TFA levels, which could greatly influence the catabolic rate and accumulation in tissues. A more detailed kinetic analysis of individual TFA isomers is necessary for a better understanding of their metabolic rates.
CONCLUSION
In the present study, we first demonstrated that the type of TFA isomer does affect its accumulation and metabolism using an in vivo model. Differences in accumulation in tissues are in part attributable to their propensities for conversion to metabolites, or differences in catabolic rates of respective isomers. These results indicate that each isomer potentially has different effects on the development of CVD. The effect of individual TFA isomers on the ratio of LDL cholesterol to HDL cholesterol LDL/HDL in blood must be investigated to identify principal isomers that affect cholesterol metabolism. It is necessary to identify specific isomers that are associated with adverse heart events based on an evaluation of differences in their metabolic and physiological activities as well as clinical research.
